Lataa...
Further hearing loss during osteoporosis treatment with etidronate.
Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
1998
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360958/ https://ncbi.nlm.nih.gov/pubmed/9799894 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|